X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/06/01/2680107/0/en/Covis-Announces-Successful-Completion-of-Its-Previously-Announced-Financial-Recapitalization-Transaction-Resulting-in-a-Material-Strengthening-of-Its-Financial-Position.html
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-withdraws-approval-covis-pharmas-preterm-birth-prevention-drug-2023-04-06/
https://www.globenewswire.com/news-release/2023/04/07/2643181/0/en/Covis-Statement-on-FDA-Decision-to-Withdraw-Approval-of-Makena.html
https://www.globenewswire.com/news-release/2023/04/03/2639400/0/en/Covis-Announces-Signing-of-Support-Agreements-With-Its-Lenders-and-Equity-Sponsors-Leading-to-a-Material-Strengthening-of-Its-Financial-Position-Including-the-Elimination-of-450-Mi.html
https://www.biopharmadive.com/news/fda-makena-withdrawal-preterm-birth-drug-covis/644418/
https://www.globenewswire.com/news-release/2023/03/07/2622609/0/en/Covis-Pharma-Responds-to-Presiding-Officer-s-Report-Summarizing-FDA-Advisory-Committee-Hearing.html
https://www.globenewswire.com/news-release/2022/10/25/2541246/0/en/Covis-Pharma-Announces-Positive-Topline-Results-from-the-AVANT-Phase-3-Clinical-Trial-Showing-Significant-Improvement-in-Patients-with-Moderate-to-Severe-Stable-COPD.html
https://www.fiercepharma.com/pharma/fda-expert-panel-votes-down-covis-preterm-birth-med-makena-latest-accelerated-approval
https://www.fiercepharma.com/pharma/fda-staffers-pull-no-punches-makena-covis-preterm-birth-drug-faces-expert-panel-reckoning
https://endpts.com/false-hopes-fda-releases-briefing-docs-on-controversial-preterm-birth-med-makena-ahead-of-adcomm/
Market Place
Share 
